Brief: Aequus and Scientus agree to collaborate for a medical Cannabis commercial supply and product development
Aug 1 (Reuters) - Aequus Pharmaceuticals Inc AQS.V
* Aequus and Scientus agree to terms for a medical Cannabis
commercial supply and product development collaboration
* Aequus Pharmaceuticals -Scientus will be supplier of
specific Cannabinoid extracts and will have an option to co-fund
clinical development of this program
* Aequus Pharmaceuticals Inc - parties expect to expand
collaboration to additional product development programs in
future
Source text for Eikon: ID:nCCNkFZw0a
Further company coverage: AQS.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Aequus Pharmaceuticals
See all newsBrief: Aequus Pharmaceutical Canada Pauses Sales Of Evolve Intensive Eyedrops, Gel In Canada
Brief: Aequus Announces Financing To Support Launch Of Zimed Preservative Free (Bimatoprost 0.03%) And Board Update
Brief: Aequus Announces Health Canada Notice Of Compliance For Zimed® Preservative Free
Brief: Aequus Announces Sandoz Contract Expiry At Year End And Expected Health Canada Approval For Zimed® Pf (Preservative Free)
Brief: Aequus Resumes Trading On TSX Venture Exchange